🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Axogen, Inc.

AXGN Healthcare
$33.13 +$1.81 (5.78%)
Market Cap: $1.72 B
Gurus Holding
4
Popularity Rank
#2597
% of Shares Held
3.48%
Net Activity (Q4 2025)
-$1.67 M

Guru Ownership Trend

Guru Analysis for Axogen, Inc. (AXGN)

Axogen, Inc. (AXGN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.01 M.

Top institutional holders include First Eagle Investment and Chuck Royce.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.67 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Chuck Royce reduced exposure by 16.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$203,482
Total Buy Value
New Buys 1
Additions 0
-$1.87 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
1

FAQs for Axogen, Inc. (AXGN)

Major holders include First Eagle Investment ($13.34 M), Chuck Royce ($5.5 M), Mairs and Power ($720,060). According to the latest reported data, 4 tracked investment managers collectively hold approximately 603,849 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.67 M, with 1 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited AXGN. The total reported sell value was $1.87 M.

Yes, 1 managers opened new positions in AXGN, and 0 increased their existing holdings. The total reported buy value was $203,482.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.02% Reduce -5.6% 407,593 $13.34 M Q4 2025
0.06% Reduce -16.4% 168,039 $5.5 M Q4 2025
0.01% 22,000 $720,060 Q4 2025
0.00% New Buy 6,217 $203,482 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form